Active surveillance can reduce overtreatment in patients with low-risk prostate cancer

Frederik Birkebæk Thomsen, Martin Andreas Røder, Helle Hvarness, Peter Iversen, Klaus Brasso

    41 Citationer (Scopus)

    Abstract

    The incidence of prostate cancer in Denmark rose approximately 50% from 2000 to 2009 in parallel with the introduction of prostate-specific antigen (PSA)-testing. Available evidence indicates a significant overtreatment of patients with low-risk prostate cancer. Active surveillance has been proposed as an observation strategy to reduce overtreatment and limit curatively intended therapy to those patients who need it. We reported the first Danish results from an active surveillance cohort.
    OriginalsprogEngelsk
    TidsskriftDanish Medical Bulletin (Online)
    Vol/bind60
    Udgave nummer2
    Sider (fra-til)A4575
    ISSN1603-9629
    StatusUdgivet - 2013

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Active surveillance can reduce overtreatment in patients with low-risk prostate cancer'. Sammen danner de et unikt fingeraftryk.

    Citationsformater